TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B News

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Nov 16 05:14

8-K: Current report

Nov 9 05:14

8-K: Current report

Oct 24 21:18

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Sire Group Ltd.(14.1%),Dato’ Seow Gim Shen(14.1%)

Aug 21 20:35

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 20 04:28

8-K: Current report

Aug 20 04:28

10-Q: Q2 2024 Earnings Report

Aug 15 21:32

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aug 15 21:32

10-Q: Q1 2024 Earnings Report

May 16 04:26

RW: Registration Withdrawal Request

Apr 26 21:43

TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Sire Group Ltd.(14.1%),Seow Gim Shen(14.1%)

Apr 6 04:39

TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 3: Initial statement of beneficial ownership of securities-Director Mokhtar Firdauz

Apr 5 22:18

TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 3: Initial statement of beneficial ownership of securities-Director Flores Francisco

Apr 5 22:18

TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 8-K: Current report

Apr 4 05:16

TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 10-K: FY2023 Annual Report

Apr 2 05:15

TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B | 8-K: Current report

Apr 2 05:11